Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe cheapest place for 10mg Mounjaro in the UK varies by provider, and the headline figure rarely tells the whole story. Private prices for Mounjaro have shifted considerably since Eli Lilly raised its UK list price in September 2025, with reported monthly costs now ranging roughly £149 to £375 depending on the dose and provider. That range is real, but what sits behind each number matters just as much as the number itself. Mounjaro (tirzepatide) is a prescription-only medicine — by law, no legitimate supplier can hand it over without a clinical assessment by a qualified prescriber, so any price you find should, at minimum, include that step.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the scenario: you're on 7.5mg, titration's gone well, and your prescriber has suggested moving to 10mg. If you're already thinking ahead, it's worth knowing that finding the cheapest place for Mounjaro 7.5mg involves the same all-in calculation that applies at every dose. Before switching, it's worth asking exactly what that price contains.
Headline costs for Mounjaro 10mg often exclude things that add up fast. Consultation fees are charged separately by some providers. Prescription fees on top of the medicine price are common. Delivery (which at the higher doses can involve cold-chain packaging) is sometimes itemised as an extra. And aftercare, meaning someone to contact if you feel unwell or have questions about your injection, is frequently absent or available only as a paid add-on.
This is a question our prescribers hear most weeks: "I've seen it cheaper elsewhere, is it the same thing?" The honest answer is that it might be, and it might not be. The price tells you nothing about whether the supply chain is licensed, whether the clinical review is thorough, or whether anyone will pick up when you need them. These details matter more at 10mg than they did at 2.5mg, because you are now at a dose where the treatment is doing real work and side-effect management is an active part of care. Those starting out can find a thorough guide to the cheapest place for Mounjaro 2.5mg, which explains what to look for in a provider from the very first pen. You can read more about how Mounjaro pricing works across doses if you want a fuller picture before comparing.
In September 2025, Eli Lilly raised its UK list price for Mounjaro, with the highest-dose pen moving from around £122 to around £330. That single change reshaped the private market. Providers who had been competing on razor-thin margins had to reprice; those who absorbed some of the increase did so by adjusting what they include.
The result is that the cheapest place for Mounjaro 10mg today is cheaper in name more often than in practice. A £30 gap between two providers frequently disappears once you add a £25 consultation fee and a £6.99 delivery charge on the lower-listed option. Our detailed breakdown of 10mg costs sets out what the market looks like after the price change and what questions to ask any provider before you commit.
Mounjaro is sourced through the licensed UK supply chain, Eli Lilly's authorised network. That supply chain has a floor. Any price significantly below what the market bears after the September 2025 list-price change is worth scrutinising carefully, because the medicine itself cannot be legitimately provided at a loss. The MHRA has warned publicly about fake weight-loss pens sold online, some of which have been found to contain insulin rather than tirzepatide. Reporting a suspect seller takes under two minutes through the Yellow Card scheme.
nume is deliberately not the cheapest option. That's not an accident. One price covers the consultation, the clinical review, the prescription, the medicine, and free next-working-day delivery by DPD in plain, unbranded packaging. There are no extras to discover at checkout. Our GPhC-registered pharmacy (registration number 9012878, verifiable at the GPhC pharmacy register) dispenses from the licensed UK supply chain, and every repeat order is reviewed by a prescriber before it goes out, no automatic renewals, no rubber-stamping.
For patients moving to 10mg specifically, that review step matters. The prescriber checks that the previous dose was tolerated, that weight progress is in line with expectations, and that there are no new factors (medications, health changes, upcoming procedures) that would affect suitability. At lower doses that might feel like a formality; at 10mg it is genuine clinical care.
Current treatment pricing is shown on the treatment page. You won't find per-pen prices in our copy because the figure that matters is what everything costs combined, not just the medicine alone. If you're comparing us to another provider, the fairest test is to add up their consultation, prescription, delivery and aftercare costs alongside ours before drawing any conclusions. Most of the time, the gap narrows considerably.
Mounjaro 10mg is not paracetamol. The dose sits two steps from the ceiling of the licensed schedule, and the people using it have typically been on treatment for five or six months already. The right questions at this stage are about clinical oversight, supply reliability and what happens if something goes wrong, not which provider has the lowest headline number.
NICE's appraisal of tirzepatide, TA1026, sets out the evidence base and eligibility criteria for Mounjaro on the NHS; understanding that context helps private patients see what a properly supervised treatment pathway looks like. The licensed eligibility for private treatment (adults with a BMI of 30 or above, or 27 or above with a weight-related condition) is assessed at consultation, not assumed from a form. Lower BMI thresholds may apply for some ethnic backgrounds under UK guidance.
If you want to explore what treatment through a clinician-led service looks like, or you have questions about moving to 10mg specifically, speak to our prescribers. The consultation is free, and you'll hear a frank clinical view rather than a sales pitch. A look at how Mounjaro costs compare across all doses might also be useful context before you decide.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.